Clinical trial
Fenofibrate in Type 2 Diabetes- Novel Biomarkers and Mechanisms
NCT03829514 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fenofibrate in Type 2 Diabetes- Novel Biomarkers and Mechanisms
- Lead sponsor
- Medical University of South Carolina
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 4, 2019
- Completion date
- March 4, 2020
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus, type ii